Plant-Derived Extracts in the Neuroscience of Anxietyon Animal Models: Biases and Comments

REFERENCES

• Lim L, Jin AZ, Ng TP. Anxiety and depression, chronic physical conditions, and quality of life in an urban population sample study. Soc Psychiatry Psychiatr Epidemiol. Forthcoming 2011 Aug 26, DOI: 10.1007/s00127-011-0420-6.
   PubMed Web of Science ®Google Scholar
• Mittal D, Fortney JC, Pyne JM, Edlund MJ, Wetherell JL. Impact of comorbid anxiety disorders on health-related quality of life among patients with major depressive disorder. Psychiatr Serv. 2006 Dec;57(12):1731–7.
   PubMed Web of Science ®Google Scholar
• Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, Katon W, Sherbourne CD. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005 Dec;43(12):1164–70.
   PubMed Web of Science ®Google Scholar
• Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000 May;157(5):669–82.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008 May-Jun;30(3):208–25.
   PubMed Web of Science ®Google Scholar
• Cimpean D, Drake RE. Treating co-morbid chronic medical conditions and anxiety/depression. Epidemiol Psychiatr Sci. 2011 Jun;20(2):141–50.
   PubMed Web of Science ®Google Scholar
• Narayanan V, Heiming RS, Jansen F, Lesting J, Sachser N, Pape HC, Seidenbecher T. Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice. PLoS One. 2011;6(7):e22600.
   Web of Science ®Google Scholar
• Tarantino LM, Sullivan PF, Meltzer-Brody S. Using animal models to disentangle the role of genetic, epigenetic, and environmental influences on behavioral outcomes associated with maternal anxiety and depression. Front Psychiatry. 2011;2:44.
   PubMedGoogle Scholar
• Kokras N, Dalla C, Sideris A, Dendi A, Mikail HG, Antoniou K, Papadopoulou-Daifoti Z. Behavioral sexual dimorphism in models of anxiety and depression due to changes in HPA axis activity. Neuropharmacology. Forthcoming 2011, DOI:10.1016/J.neuropharm.2011.08.025.
   PubMed Web of Science ®Google Scholar
• Hettema JM, Webb BT, Guo AY, Zhao Z, Maher BS, Chen X, An SS, Sun C, Aggen SH, Kendler KS, Kuo PH, Otowa T, Flint J, van den Oord EJ. Prioritization and association analysis of murine-derived candidate genes in anxiety-spectrum disorders. Biol Psychiatry. Forthcoming 2011 , DOI:10.1016 /j.biopsych.2011.07.012.
   Web of Science ®Google Scholar
• Graham BM, Milad MR. The study of fear extinction: implications for anxiety disorders. Am J Psychiatry. Forthcoming 2011 Aug 24, DOI: 10.1176/appi.ajp.2011.11040557.
   PubMed Web of Science ®Google Scholar
• Chang CH, Knapska E, Orsini CA, Rabinak CA, Zimmerman JM, Maren S. Fear extinction in rodents. Curr Protoc Neurosci. 2009 Apr; Chapter 8:Unit 8.23.
   PubMedGoogle Scholar
• Magnani P, Conforti A, Zanolin E, Marzotto M, Bellavite P. Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. Psychopharmacology (Berl). 2010 Jul;210(4):533–45.
   PubMed Web of Science ®Google Scholar
• Korte SM, De Boer SF. A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze. Eur J Pharmacol. 2003 Feb 28;463(1–3):163–75.
   PubMed Web of Science ®Google Scholar
• Korte SM, De Boer SF, Bohus B. Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning. Stress. 1999 Aug;3(1):27–40.
   PubMedGoogle Scholar
• Grahn RE, Kalman BA, Brennan FX, Watkins LR, Maier SF. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Pharmacol Biochem Behav. 1995 Nov;52(3):565–70.
   PubMed Web of Science ®Google Scholar
• Chirumbolo S. Gelsemine and Gelsemium sempervirens L. extracts in animal behavioral test: comments and related biases. Front Neurol. 2011;2:31.
   PubMedGoogle Scholar
• Bellavite P. Gelsemium sempervirens and animal behavioral models. Front Neurol. 2011;2:56, DOI: 10.3389 /fneur.2011.00056.
   PubMedGoogle Scholar
• Ernst E. Herbal remedies for anxiety: a systematic review of controlled clinical trials. Phytomedicine. 2006 Feb;13(3):205–8.
   PubMed Web of Science ®Google Scholar
• Cassileth B. Kava (Piper methysticum). Oncology (Williston Park). 2011 Apr 15;25(4):384–5.
   PubMedGoogle Scholar
• Sarris J, La Porte E, Schweitzer I. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust N Z J Psychiat. 2011 Jan;45(1):27–35.
   PubMed Web of Science ®Google Scholar
• Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 2000 Feb;20(1):84–9.
   PubMed Web of Science ®Google Scholar
• Pittler MH, Edzard E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2001;4: CD003383.
   PubMedGoogle Scholar
• Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2002;2: CD003383.
   Google Scholar
• Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003;1: CD003383.
   PubMedGoogle Scholar
• Lee YJ, Lee YM, Lee CK, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011 May;130(2):157–76.
   PubMed Web of Science ®Google Scholar
• Kumar S, Sharma A. Anti-anxiety activity studies of various extracts of Turnera aphrodisiaca Ward. J Herb Pharmacother. 2005;5(4):13–21.
   PubMedGoogle Scholar
• Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia. 2001 Dec;72(8):922–6.
   PubMed Web of Science ®Google Scholar
• Demers, J. Gelsemium sempervirens. J Am Holistic Vet Med Assoc. 1998;16(4):21–22.
   Google Scholar
• Dutt V, Dhar VJ, Sharma A. Antianxiety activity of Gelsemium sempervirens. Pharm Biol. 2010 Oct;48(10):1091–6.
   PubMed Web of Science ®Google Scholar
• Hui KM, Huen MS, Wang HY, Zheng H, Sigel E, Baur R, Ren H, Li ZW, Wong JT, Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol. 2002 Nov 1;64(9):1415–24.
   PubMed Web of Science ®Google Scholar
• Duke, JA. Handbook of phytochemical constituents of GRAS herbs and other economic plants. Boca Raton, FL: CRC Press; 1992.
   Google Scholar
• Takayama H, Sakai SI. Gelsemium alkaloyds. In Cordell GA, editor. The alkaloyds: chemistry and pharmacology. Amsterdam: Elsevier; 1997. Vol. 49, p. 1–78.
   Google Scholar
• Zhang Z, Wang P, Yuan W, Li S. Steroids, alkaloids, and coumarins from Gelsemium sempervirens. Planta Med. 2008 Dec;74(15):1818–22.
   PubMed Web of Science ®Google Scholar
• Nogure N, Nishiya C, Kitajima M, Takayama H. Six new alkaloids from Gelsemium sempervirens Ait. f. Thetrahedron Lett. 2005;46:5847–61.
   Web of Science ®Google Scholar
• Schun Y, Cordell GA. Cytotoxic steroids of Gelsemium sempervirens. J Nat Prod. 1987;50(2)195–8.
   PubMed Web of Science ®Google Scholar
• Williamson EM, Evans FJ. Potter's new encyclopaedia of botanical drugs and preparations. Rev. ed. Essex: Saffron Walden, the C. W. Daniel Co., Ltd.; 1988. 362 p. Reprint 1989.
   Google Scholar
• Gahlot K, Abid M, Sharma A. Pharmacological evaluation of Gelsemium sempervirens roots for CNS depressant activity. Int J Pharmatech Res. 2011;3(2):693–7.
   Google Scholar
• Bellavite P, Magnani P, Zanolin E, Conforti A. Homeopathic doses of Gelsemium sempervirens improve the behavior of mice in response to novel environments. Evid Based Complement Altern Med. 2011;2011: Art. ID 362517, 10 pp. DOI:10.1093 /ecam/nep139.
   PubMed Web of Science ®Google Scholar
• Venard C, Boujedaini N, Mensah-Nyagan AG, Patte-Mensah C. Comparative analysis of gelsemine and Gelsemium sempervirens activity on neurosteroid allopregnanolone formation in the spinal cord and limbic system. Evid Based Complement Alternat Med. 2009 Jul 23; Art. ID 407617, DOI:10.1093/ecam/nep083.
   Web of Science ®Google Scholar
• Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011, DOI:10.1016/j.euroneuro.2011.04.002.
   PubMed Web of Science ®Google Scholar
• Williamson EH. Synergy and other interactions in phytomedicine. Phytomedicine. 2001;8(5):401–9.
   PubMed Web of Science ®Google Scholar
• Barreiro Arcos ML, Cremaschi G, Werner S, Coussio J, Ferraro G, Anesini C. Tilia cordata Mill. Extracts and scopoletin (isolated compound): differential cell growth effects on lymphocytes. Phytother Res. 2006 Jan;20(1):34– 40.
   PubMed Web of Science ®Google Scholar
• Capra JC, Cunha MP, Machado DG, Zomkowski AD, Mendes BG, Santos AR, Pizzolatti MG, Rodrigues AL. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur J Pharmacol. 2010 Sep 25;643(2–3):232–8.
   PubMed Web of Science ®Google Scholar
• Hornick A, Lieb A, Vo NP, Rollinger J, Stuppner H, Prast H. Effects of the coumarin scopoletin on learning and memory, on release of acetylcholine from brain synaptosomes and on long-term potentiation in hippocampus. BMC Pharmacol. 2008;8(Suppl 1):A36.
   Google Scholar
• Rollinger JM, Hornick A, Langer T, Stuppner H, Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products. J Med Chem. 2004 Dec 2;47(25):6248–54.
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007 Apr;14(4):289–300.
   PubMed Web of Science ®Google Scholar
• Venard C, Boujedaini N, Belon P, Mensah-Nyagan AG, Patte-Mensah C. Regulation of neurosteroid allopregnanolone biosynthesis in the rat spinal cord by glycine and the alkaloidal analogs strychnine and gelsemine. Neuroscience. 2008 Apr 22;153(1):154–61.
   PubMed Web of Science ®Google Scholar
• Chillingsworth FP. Physiological study of gelsemine and gelseminine. J Am Pharmac Assoc. 1914;3(3):315–21.
   Google Scholar
• Yevenes GE, Zeilhofer HU. Allosteric modulation of glycine receptors. Br J Pharmacol. 2011 May 10, DOI: 10.1111/ j.1476–5381.2011.01471.
   PubMed Web of Science ®Google Scholar
• Wang DV, Wang F, Liu J, Zhang L, Wang Z, Lin L. Neurons in the amygdala with response-selectivity for anxiety in two ethologically based tests. PLoS One. 2011;6(4):e18739.
   Web of Science ®Google Scholar
• Zhang CG, Kim SJ. Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo. Annals Nutr Metab. 2007;51(4):379–86.
   PubMed Web of Science ®Google Scholar
• Riering K, Rewerts C, Zieglgansberger W. Analgesic effect of 5-HT3 receptor antagonists. Scand J Rheumatol. 2004;33(219):19–23.
   PubMedGoogle Scholar
• Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M. The sedative component of anesthesia is mediated by GABA-A receptors in an endogenous sleep pathway. Nat Neurosci. 2002 Oct;5(10):979–84.
   PubMed Web of Science ®Google Scholar
• Forman SA, Miller KW. Anesthetic sites and allosteric mechanisms of action on cys-loop ligand-gated ion channels. Can J Anaesth. 2011;58:191–205.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Lester HA, Lummis SC. The structural basis of function in cys-loop receptors. Q Rev Biophys. 2010 Nov;43(4):449–99.
   PubMed Web of Science ®Google Scholar
• Olsen RW, Li GD. GABA-A receptors as molecular targets of general anesthetics: identification of binding sites provides clues to allosteric modulation. Can J Anaesth. 2011 Feb;58(2):206–15.
   PubMed Web of Science ®Google Scholar
• Chisari M, Eisenman LN, Covey DF, Mennerick S, Zorumski CF. The sticky issue of neurosteroids and GABA-A receptors. Trends Neurosci. 2010 Jul;33(7):299–306.
   PubMed Web of Science ®Google Scholar
• Hosie AM, Wilkins ME, Smart TG. Neurosteroid binding sites on GABA-A receptors. Pharmacol Ther. 2007 Oct;116(1):7–19.
   PubMed Web of Science ®Google Scholar
• Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog Neurobiol. 2003 Sep;71(1):67–80.
   PubMed Web of Science ®Google Scholar
• Lambert JJ, Cooper MA, Simmons RD, Weir CJ, Belelli D. Neurosteroids: endogenous allosteric modulators of GABA-A receptors. Psychoneuroendocrinology. 2009 Dec;34(Suppl 1):S48–58.
   Google Scholar
• Rudolph U, Mohler H. GABA-based therapeutic approaches: GABA-A receptor subtype functions. Curr Opin Pharmacol. 2006;6:18–23.
   PubMed Web of Science ®Google Scholar
• Mitchell EA, Herd MB, Gunn BG, Lambert JJ, Belelli D. Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochem Int. 2008 Mar-Apr;52(4–5):588–95.
   PubMed Web of Science ®Google Scholar
• Tsetlin V, Kuzmin D, Kasheverov I. Assembly of nicotinic and other cys-loop receptors. J Neurochem. 2011 Mar;116(5):734–41.
   PubMed Web of Science ®Google Scholar
• Lader M. Effectiveness of benzodiazepines: do they work or not? Expert Rev Neurother. 2008 Aug;8(8):1189–91.
   PubMedGoogle Scholar
• Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J Psychopharmacol. 2007 Sep;21(7):774–82.
   PubMed Web of Science ®Google Scholar
• Atack JR. GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics. Curr Top Behav Neurosci. 2010;2:331–60.
   PubMedGoogle Scholar
• Auta J, Kadriu B, Giusti P, Costa E, Guidotti A. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives. Pharmacol Biochem Behav. 2010 Jun;95(4):383–9.
   PubMed Web of Science ®Google Scholar
• Smoothy R, Berry MS. Alcohol increases both locomotion and immobility in mice: an ethological analysis of spontaneous motor activity. Psychopharmacology. 1984;83(3):272–6.
   PubMed Web of Science ®Google Scholar
• Araujo NP, Andersen ML, Abílio VC, Gomes DC, Carvalho RC, Silva RH, Ribeiro Rde A, Tufik S, Frussa-Filho R. Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice. Brain Res Bull. 2006 Apr 14;69(3):332–7.
   PubMed Web of Science ®Google Scholar
• Chuck TL, McLaughlin PJ, Arizzi-LaFrance MN, Salamone JD, Correa M. Comparison between multiple behavioral effects of peripheral ethanol administration in rats: sedation, ataxia, and bradykinesia. Life Sci. 2006 Jun 6;79(2): 154–61.
   PubMed Web of Science ®Google Scholar
• Biggio G, Concas A, Follesa P, Sanna E, Serra M. Stress, ethanol, and neuroactive steroids. Pharmacol Ther. 2007 Oct;116(1):140–71.
   PubMed Web of Science ®Google Scholar
• Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology. Forthcoming 2011 Aug 18 , DOI:10.1016/j.neuropharm.2011.08.018.
   PubMed Web of Science ®Google Scholar
• Kronfeld-Schor N, Einat H. Circadian rythms and depression: human psychopathology and animal models. Neuropharmacology. Forthcoming 2011 , DOI: 10.1016 /j.neuropharm.2011.08.020.
   PubMed Web of Science ®Google Scholar
• Bishop SJ. Neurocognitive mechanisms of anxiety: an integrative account. Trends Cogn Sci. 2007 Jul;11(7):307–16.
   PubMed Web of Science ®Google Scholar
• Indovina I, Robbins TW, Núñez-Elizalde AO, Dunn BD, Bishop SJ. Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron. 2011 Feb 10;69(3):563–71.
   PubMed Web of Science ®Google Scholar
• Quartermain D, Clemente J, Shemer A. 5-HT1A agonists disrupt memory of fear conditioning in mice. Biol Psychiat. 1993 Feb 15;33(4):247–54.
   PubMed Web of Science ®Google Scholar
• Sanger DJ, Joly D. Anxiolytic drugs and the acquisition of fear conditioning in mice. Psychopharmacology (Berl). 1985;85(3):284–8.
   PubMed Web of Science ®Google Scholar
• Brignell CM, Curran HV. Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning. Psychopharmacology (Berl). 2006 Jul;186(4):504–16.
   PubMed Web of Science ®Google Scholar
• Bellavite P, Magnani P, Marzotto M, Conforti A. Assays of homeopathic remedies in rodent behavioral and psychopathological models. Homeopathy. 2009;98(4):208–27.
   PubMed Web of Science ®Google Scholar
• Tan KR, Rudolph U, Lüscher C. Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci. 2011 Apr;34(4):188–97.
   PubMed Web of Science ®Google Scholar
• Bond AJ, Wingrove J, Baylis M, Dalton J. Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli. Psychopharmacology (Berl). 2003 Jan;165(3):291–5.
   PubMed Web of Science ®Google Scholar
• Crawley JN. Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev. 1985;9(1):37–44.
   PubMed Web of Science ®Google Scholar
• Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003;463(1–3):3–33.
   PubMed Web of Science ®Google Scholar
• Jain A, Dvorkin A, Fonio E, Golani I, Gross CT. Validation of the dimensionality emergence assay for the measurement of innate anxiety in laboratory mice. Eur Neuropsychopharmacol. Forthcoming 2011 , DOI: 10.1016 /j.euroneuro.2011.07.001.
   PubMed Web of Science ®Google Scholar
• Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice: influence of dopaminergic transmissions. Behav Brain Res. 1994 Mar 31;61(1):59–64.
   PubMed Web of Science ®Google Scholar
• Bourin M, Hascoet M. The mouse light/dark box test. Eur J Phrmacol. 2003;463(1–3):55–65.
   PubMed Web of Science ®Google Scholar
• Hascoet M, Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav. 1998;60(3):645–53.
   PubMed Web of Science ®Google Scholar
• Overstreet DH, Commissaris RC, De La Garza R II, File SE, Knapp DJ, Seiden LS. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress. 2003 Jun;6(2):101–10.
   PubMed Web of Science ®Google Scholar
• Karl T, Duffy L, Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci. 2008 Jul;28(1):173–80.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate. Crit Rev Toxicol. 2008;38(6):489–542.
   PubMed Web of Science ®Google Scholar
• Lewejohann L, Reinhard C, Schrewe A, Brandewiede J, Haemisch A, Gortz N, Schrachner M, Sachser N. Environmental bias? Effects of housing conditions, laboratory environment and experimenter on behavioral tests. Genes Brain Behav. 2006;5(1):64–72.
   PubMed Web of Science ®Google Scholar
• Vexler A, Tsai VM, Malinovsky Y. Estimation and testing based on data subject to measurement errors: from parametric to non-parametric likelihood methods. Stat Med. Forthcoming 2011 , DOI: 10.1002 /sim.4304.
   PubMed Web of Science ®Google Scholar
• McLeod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004;35(5):1203–8.
   PubMed Web of Science ®Google Scholar
• Jennions MD, Møller AP. A survey on the statistical power of research in behavioral ecology and animal behavior. Behav Ecol. 2003;14:438–45.
   Web of Science ®Google Scholar
• Nakagawa S. A farewell to Bonferroni: the problems of low statistical power and publication bias. Behav Ecol. 2004;15(6):1044–5.
   Web of Science ®Google Scholar
• Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat. 2001;55:19–24.
   Web of Science ®Google Scholar
• Adebiyl AO. Bias: a review of current understanding. Afr J Med Med Sci. 2010;39(3):241–8.
   PubMedGoogle Scholar
• Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, Hing C, Kwok CS, Pang C, Harvey I. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess. 2010;14(8):1–220.
   Web of Science ®Google Scholar
• Longordo F, Fan J, Steimer T, Kopp C, Luthl A. Do mice habituate to “gentle handling”? A comparison of resting behavior, corticosterone levels and synaptic function in handled and undisturbed C57BL/6J mice. Sleep. 2011;34(5):679–81.
   PubMed Web of Science ®Google Scholar
• Podsakoff PM, MacKenzie SB, Lee JY, Podsakoff NP. Common method biases in behavioral research: a critical review of he literature and recommended remedies. J Appl Psychol. 2003;88(5):879–903.
   PubMed Web of Science ®Google Scholar
• Ackermann TF, Hörtnagl H, Wolfer DP, Colacicco G, Sohr R, Lang F, Hellweg R, Lang UE. Phosphatidylinositide dependent kinase deficiency increases anxiety and decreases GABA and serotonin abundance in the amygdala. Cell Physiol Biochem. 2008;22(5–6):735–44.
   PubMed Web of Science ®Google Scholar
• Tohda C, Nakanishi R, Kadowaki M. Hyperactivity, memory deficit and anxiety-related behaviors in mice lacking the p85alpha subunit of phosphoinositide-3 kinase. Brain Dev 2009 Jan;31(1):69–74.
   PubMed Web of Science ®Google Scholar